EDITORIAL
Published on 24 Feb 2021
Editorial: Complement and Immunotherapeutics
doi 10.3389/fimmu.2021.663459
- 1,951 views
- Frontiers in Immunology
- Molecular Innate Immunity
- Research Topics
- Complement and Immunotherapeutics
Complement and Immunotherapeutics
31k
Total downloads
127k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 11 Feb 2021
The Role of Alpha 2 Macroglobulin in IgG-Aggregation and Chronic Activation of the Complement System in Patients With Chronic Lymphocytic Leukemia
doi 10.3389/fimmu.2020.603569
- 3,229 views
- 9 citations
REVIEW
Published on 11 Feb 2021
Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys
doi 10.3389/fimmu.2020.599974
- 9,505 views
- 53 citations
CASE REPORT
Published on 15 Jan 2021
Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
doi 10.3389/fimmu.2020.612706
- 2,905 views
- 11 citations
REVIEW
Published on 11 Jan 2021
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target
doi 10.3389/fimmu.2020.599117
- 22,944 views
- 75 citations
ORIGINAL RESEARCH
Published on 11 Jan 2021
Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength
doi 10.3389/fimmu.2020.609941
- 7,402 views
- 24 citations
REVIEW
Published on 08 Jan 2021
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
doi 10.3389/fimmu.2020.603039
- 9,265 views
- 52 citations
REVIEW
Published on 10 Dec 2020
Therapeutic Lessons to be Learned From the Role of Complement Regulators as Double-Edged Sword in Health and Disease
doi 10.3389/fimmu.2020.578069
- 4,394 views
- 14 citations
ORIGINAL RESEARCH
Published on 10 Dec 2020
Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
doi 10.3389/fimmu.2020.612402
- 11,786 views
- 25 citations
ORIGINAL RESEARCH
Published on 19 Nov 2020
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
doi 10.3389/fimmu.2020.584509
- 5,495 views
- 15 citations
ORIGINAL RESEARCH
Published on 26 Oct 2020
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
doi 10.3389/fimmu.2020.583305
- 3,283 views
- 8 citations
ORIGINAL RESEARCH
Published on 16 Oct 2020
C2 IgM Natural Antibody Enhances Inflammation and Its Use in the Recombinant Single Chain Antibody-Fused Complement Inhibitor C2-Crry to Target Therapeutics to Joints Attenuates Arthritis in Mice
doi 10.3389/fimmu.2020.575154
- 3,535 views
- 8 citations
